SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 4, 2010, Pages 386-394

  Sharma, Nidhi ^a   Deshmukh, Rahul ^a   Bedi, K L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Alzheimer's disease; Dementia; JNK; Neurocognitive dysfunction; Oxidative stress; SP600125; Streptozotocin

Indexed keywords

ACETYLCHOLINESTERASE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LACTATE DEHYDROGENASE; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CHOLINERGIC SYSTEM; CHRONIC DRUG ADMINISTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; LEARNING DISORDER; MALE; MEMORY DISORDER; NERVE CELL LESION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPATIAL MEMORY;

ACETYLCHOLINESTERASE; ANIMALS; ANTHRACENES; AVOIDANCE LEARNING; BRAIN; COGNITION DISORDERS; GLUTATHIONE; INJECTIONS, INTRAVENTRICULAR; L-LACTATE DEHYDROGENASE; MALE; MAP KINASE KINASE 4; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; RATS; STREPTOZOCIN;

RATTUS;

EID: 77956062838     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.06.010     Document Type: Article

References (67)

1. Arendt T. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization (Review). Neuroscience 2001, 102:723-765.
2. Barker G.R.I., Bird F., Alexander V., Warburton E.C. Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J Neurosci 2007, 27:2948-2957.
3. Barry C.E., Nolan Y., Clarke R.M., Lynch A., Lynch M.A. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J Neurochem 2005, 93:221-231.
4. Bennett B., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., et al. SP600125, an anthrapyrazole inhibitor of jun N-terminal kinase. Proc Natl Acad Sci USA 2001, 98:13681-13686.
5. Bevilaqua L., Kerr D.S., Medina J.H., Izquierdo I., Cammarota M. Inhibition of hippocampal Jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. Eur J Neurosci 2003, 17:897-902.
6. Bogoyevitch M.A., Boehm I., Oakley A., Ketterman A.J., Barr R.K. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 2004, 1697:89-101.
7. Brecht S., Kirchhof R., Chromik A., Willesen M., Nicolaus T., Raivich G., et al. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 2005, 21:363-377.
8. Bruce-Keller A.J., Li Y.J., Lovell A., Kramer P.J., Gray D.S., Brown R.R., et al. 4-hydroxinonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rat. J Neuropathol Exp Neurol 1998, 57:257-267.
9. Butcher L.L., Woolf N.J., Scheibel A.B., Wechsler A.F. Central cholinergic systems: synopsis of anatomy and overview of physiology and pathology. The Biological Substrate of Alzheimer's Diseases 1986, 73-86. Acad Press, NY.
10. Carboni S., Boschert U., Gaillard P., Gotteland J.P., Gillon J.Y., Vitte P.A., et al. AS601245, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduces axon/dendrite damage and cognitive deficits after global cerebral ischaemia in gerbils. Br J Pharmacol 2008, 153:157-163.
11. Choi E.J., Lee B.H. Evidence for genistein mediated cytotoxicity and apoptosis in rat brain. Life Sci 2004, 75:499-502.
12. Chong Z.Z., Li F., Maiese K. Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease. Brain Res Rev 2005, 49:1-21.
13. Colombo A., Repici M., Pesaresi M., Santambrogio S., Forloni G., Borsello T. The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability. Cell Death Differ 2007, 14:1845-1848.
14. Costello D.A., Herron C.E. The role of c-Jun N-terminal kinase in the A beta-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology 2004, 46:655-662.
15. Davil D., Torres-Aleman I. Neuronal death by oxidative stress involves activation of FOXO3 through a two-arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol Biol Cell 2008, 19:2014-2025.
16. Deshmukh R., Sharma V., Mehan S., Sharma N., Bedi K.L. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine-a PDE1 inhibitor. Eur J Pharmacol 2009, 620:49-56.
17. Dias-Santagata D., Fulga T.A., Duttaroy A., Feany M.B. Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J Clin Invest 2007, 117:236-245.
18. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 1959, 82:70-74.
19. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. Anewand rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 7:88-95.
20. Esneault E., Castagne V., Moser P., Bonny C., Bernaudin M. D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats. Neuroscience 2008, 152:308-320.
21. Francis P.T., Palmer A.M., Snape M., Wilcock F.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress (Review). J Neurol Neurosurg Psychiatry 1999, 66:137-147.
22. Green L.C., Wagner D.A., Glgowski J., Skipper P.L., Wishnok J.S., Tannebaum S.R. Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Ann Biochem Exp Med 1982, 126:131-135.
23. Grunblatt E., Petrisic M.S., Osmanovic J., Riederer P., Hoyer S. Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 2007, 101:757-770.
24. Guan Q.H., Pei D.S., Zong Y.Y., Xu T.L., Zhang G.Y. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 2006, 139:609-627.
25. Hartman S. Free radicals theory of aging: Alzheimer's disease pathogenesis. Age 1995, 18:97-119.
26. Hartman R.E., Lee J.M., Zipfel G.J., Wozniak D.F. Characterizing learning deficits and hippocampal neuron loss following transient global cerebral ischemia in rats. Brain Res 2005, 1043:48-56.
27. Hooge R.D., Deyn P. Application of the Morris water maze in the study of learning and memory. Brain Res Rev 2001, 36:60-90.
28. Hoyer S., Lannert H. Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein. J Neural Transm 2007, (Suppl 72):195-202.
29. Hunot S., Vila M., Teismann P., Davis R.J., Hirsch E.C., Przedborski S., et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2004, 101:665-670.
30. Johnson G.L., Nakamura K. The c-Jun kinase/stress activated pathway: regulation, function and role in human disease. Biochem Biophys Acta 2007, 1773:1341-1348.
31. Kuan C., Burke R.E. Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord 2005, 4:63-67.
32. Kuan C.Y., Whitmarsh A.J., Yang D.D., Liao G., Schloemer A.J., Dong C., et al. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci USA 2003, 100:15184-15189.
33. Lannert H., Wirtz P., Schuhmann V., Galmbacher R. Effects of estradiol (-17beta) on learning, memory and cerebral energy metabolism in male rats after intracerebroventricular administration of streptozotocin. J Neural Transm 1998, 105:1045-1063.
34. Lehtinen M.K. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell 2006, 125:987-1001.
35. Lenard L., Kertes E. Influence of passive avoidance learning by substance P in the basolateral amygdala. Acta Biol Hung 2002, 53:95-104.
36. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., et al. Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 1990, 186:464-487.
37. Li X.M., Li C.C., Yu S.S., Chen J.T., Sabapathy K., Ruan D.Y. JNK1 contributes to metabotropic glutamate receptor-dependent longterm depression and short-term synaptic plasticity in the mice area hippocampal CA1. Eur J Neurosci 2007, 25:391-396.
38. Liu R., Liu I.Y., Bi X., Thompson R.F., Doctrow S.R., Malfroy B. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci USA 2001, 100:8526-8531.
39. Lowry O.H., Roseburgh N.J., Farr A.L., Randal R.L. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:205-215.
40. Maiese K., Chong Z.Z. Insight into oxidative stress and potential novel therapeutic target for Alzhiemer's disease. Restor Neurol Neurosci 2004, 22:87-104.
41. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 1999, 23:134-147.
42. McGeer P.L., McGeer E.G. Inflammation, autotoxicity and Alzheimer's disease. Neurobiol Aging 2001, 22:799-809.
43. Moreira P.I., Honda K., Liu Q., Alviev G., Oliveira C.R., Santos M.S., et al. Alzheimer's disease and oxidative stress: the old problem remains unsolved. Curr Med Chem-CNS Agents 2005, 5:51-62.
44. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., et al. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c- Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001, 21:7551-7560.
45. Morris R.G.M. Development of a water-maze procedure for studying spatial learning in the rats. J Neurosci Meth 1984, 11:47-60.
46. Mumby D.G. Perspectives on object-recognition memory following hippocampal damage: lessons from studies in rats. Behav Brain Res 2001, 127:159-181.
47. Nagel J.A., Kemble E.D. Effects of amygdale lesions on the performance of rats in four passive avoidance tasks. Physiol Behav 1976, 17:245-250.
48. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Acad Press, Sydney. 2nd ed.
49. Popic P., Nalepa I., Mamczarz J., Vetulani J. Retrieval associated cholinergic activity and its inhibition by memory updating. Life Sci 1994, 54:1251-1257.
50. Pratico D., Delanty N. Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease. Am J Med 2000, 109:577-585.
51. Raivich G., Bohatschek M., Da Costa C., Iwata O., Galiano M., Hristova M., et al. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 2004, 43:57-67.
52. Repici M., Borsello T. JNK pathway as therapeutic target to prevent degeneration in the central nervous system. Adv Exp Med Biol 2006, 588:145-155.
53. Salkovic-Petrisic M., Hoyer S. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm 2007, 72:217-233. (Suppl.).
54. Sharma M., Gupta Y.K. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci 2001, 68:1021-1029.
55. Sharma M., Gupta Y.K. Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur Neuropsychopharmacol 2003, 13:241-247.
56. Shoham S., Bejar C., Kovalev E., Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 2003, 184:1043-1052.
57. Shoham S., Bejar C., Kovalev E., Schorer-Apelbaum D., Weinstock M. Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 2007, 52:836-843.
58. Stuchbury G., Munch G. Alzheimer's associated inflammation, potential drug targets and future therapies. J Neural Transm 2005, 112:429-453.
59. Tuppo E.E., Arias H.R. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005, 37:289-305.
60. Waetzig V., Czeloth K., Hidding U., Mielke K., Kanzow M., Brecht S., et al. C-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 2005, 50:235-346.
61. Wickens A.P. Ageing and the free radical theory. Respir Physiol 2001, 28:379-391.
62. Wills E.D. Mechanism of lipid peroxide formation in animal tissue. Biochem J 1966, 99:667-676.
63. Yang Y., Zhu X., Chen Y., Wang X., Chen R. p38 and JNK MAPK, but not ERK1/2 MAPK, play important role in colchicines-induced cortical neurons apoptosis. Eur J Pharmacol 2007, 576:26-33.
64. Yeste-Velasco M., Folch J., Casadesus G., Smith M., Pallas M., Camins A., et al. Neuroprotection by c-Jun NH2 terminal kinase inhibitor SP600125 against potassium deprivation induced apoptosis involvs the Akt pathway and inhibition of cell cycle re-entry. Neuroscience 2009, 159:1135-1147.
65. Zhao Y., Herdegen T. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria. Mol Cell Neurosci 2009, 41:186-195.
66. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., et al. Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J Neurochem 2001, 76:435-441.
67. Zhu X., Rottkamp C.A., Hartzler A., Sun Z., Takeda A., Boux H. Activation of MKK6, an upstream activator of p38, in Alzheimer's disease. J Neurochem 2001, 79:311-318.